{"organizations": [], "uuid": "2d8d8367b33b16c380b57047ac56ab8b90b96890", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-thrombogenics-initiates-phase-2-cl/brief-thrombogenics-initiates-phase-2-clinical-study-for-treatment-of-diabetic-macular-edema-idUSFWN1S4040", "country": "US", "domain_rank": 408, "title": "BRIEF-Thrombogenics Initiates Phase 2 Clinical Study For Treatment Of Diabetic Macular Edema", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-27T08:55:00.000+03:00", "replies_count": 0, "uuid": "2d8d8367b33b16c380b57047ac56ab8b90b96890"}, "author": "", "url": "https://www.reuters.com/article/brief-thrombogenics-initiates-phase-2-cl/brief-thrombogenics-initiates-phase-2-clinical-study-for-treatment-of-diabetic-macular-edema-idUSFWN1S4040", "ord_in_thread": 0, "title": "BRIEF-Thrombogenics Initiates Phase 2 Clinical Study For Treatment Of Diabetic Macular Edema", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "treatment of diabetic macular edema", "sentiment": "negative"}, {"name": "treatment of diabetic macular edema reuters", "sentiment": "none"}, {"name": "macular edema", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - THROMBOGENICS NV:\n* THROMBOGENICS INITIATES PHASE 2 CLINICAL STUDY EVALUATING ANTI-PLGF (THR-317) IN COMBINATION WITH ANTI-VEGF (RANIBIZUMAB) FOR TREATMENT OF DIABETIC MACULAR EDEMA (DME)\n* INITIAL RESULTS FROM THR-317-002 STUDY ARE ANTICIPATED IN Q3 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": [], "published": "2018-04-27T08:55:00.000+03:00", "crawled": "2018-04-27T09:13:50.006+03:00", "highlightTitle": ""}